Orbimed Advisors - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2020$67,638,000
+456.8%
601,066
+371.4%
0.85%
+397.1%
Q2 2020$12,147,000
-47.5%
127,500
-50.5%
0.17%
-56.0%
Q1 2020$23,146,000
+306.1%
257,549
+139.6%
0.39%
+380.2%
Q4 2019$5,700,000
-2.3%
107,500
-37.4%
0.08%
+17.4%
Q2 2014$5,836,000
-90.9%
171,800
-90.8%
0.07%
-91.3%
Q1 2014$64,439,000
-23.2%
1,867,800
-11.8%
0.79%
-35.7%
Q4 2013$83,859,0002,117,6481.23%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Polaris Venture Management Co IV LLC 1,480,060$53,563,00085.86%
NEXTHERA CAPITAL LP 217,817$7,883,0004.84%
Novo Holdings A/S 903,833$32,710,0002.90%
SECTORAL ASSET MANAGEMENT INC 481,765$17,435,0001.71%
Perceptive Advisors 589,890$21,348,0001.38%
RA Capital Management 318,565$11,529,0001.19%
OAK RIDGE INVESTMENTS LLC 1,226,468$44,386,0001.15%
Granahan Investment Management 817,149$29,573,0000.97%
Eventide Asset Management 428,900$15,522,0000.95%
QVT Financial LP 636,764$23,044,0000.87%
View complete list of ACCELERON PHARMA INC shareholders